-
Treatment of benign prostatic hyperplasia by natural drugs [Elektronski vir]Csikós, Eszter ...Benign prostatic hyperplasia (BPH) is one of the most common urinary diseases affecting men, generally after the age of 50. The prevalence of this multifactorial disease increases with age. With ... aging, the plasma level of testosterone decreases, as well as the testosterone/estrogen ratio, resulting in increased estrogen activity, which may facilitate the hyperplasia of the prostate cells. Another theory focuses on dihydrotestosterone (DHT) and the activity of the enzyme 5[alpha]-reductase, which converts testosterone to DHT. In older men, the activity of this enzyme increases, leading to a decreased testosterone/DHT ratio. DHT may promote prostate cell growth, resulting in hyperplasia. Some medicinal plants and their compounds act by modulating this enzyme, and have the above-mentioned targets. This review focuses on herbal drugs that are most widely used in the treatment of BPH, including pumpkin seed, willow herb, tomato, maritime pine bark, Pygeum africanum bark, rye pollen, saw palmetto fruit, and nettle root, highlighting the latest results of preclinical and clinical studies, as well as safety issues. In addition, the pharmaceutical care and other therapeutic options of BPH, including pharmacotherapy and surgical options, are discussed, summarizing and comparing the advantages and disadvantages of each therapy.Vir: Molecules [Elektronski vir]. - ISSN 1420-3049 (Vol. 26, iss. 23, 2021, str. 1-32)Vrsta gradiva - e-članek ; neleposlovje za odrasleLeto - 2021Jezik - angleškiCOBISS.SI-ID - 86644739
Avtor
Csikós, Eszter |
Horváth, Adrienn |
Ács, Kamilla |
Papp, Nóra |
Balázs, Viktória Lilla |
Sollner Dolenc, Marija |
Kenda, Maša, farmacevtka |
Kočevar Glavač, Nina |
Nagy, Milan, pharmacist |
Protti, Michele
Teme
Benigna prostatična hiperplazija |
Zdravilne rastline |
Fitoterapija |
predklinične študije |
klinična učinkovitost |
varnostne težave |
benign prostatic hyperplasia |
medicinal plants |
phytotherapy |
saw palmetto |
preclinical studies |
clinical efficacy |
safety issues
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Csikós, Eszter | |
Horváth, Adrienn | |
Ács, Kamilla | |
Papp, Nóra | |
Balázs, Viktória Lilla | |
Sollner Dolenc, Marija | 08519 |
Kenda, Maša, farmacevtka | 39201 |
Kočevar Glavač, Nina | 26495 |
Nagy, Milan, pharmacist | |
Protti, Michele |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.